Current therapeutic strategies of heterotopic ossification – a survey amongst orthopaedic and trauma departments in Germany

BMC Musculoskeletal Disorders

Tobias Renkawitz¹  Joachim Grifka¹  Hans Robert Springorum¹  Guido Heers¹  Benjamin Craiovan¹  Jan Matussek¹  Markus Weber¹  Ferdinand Wagner¹  Sebastian Winkler¹ 

[1] Department of Orthopaedic Surgery, Regensburg University Medical Centre, Kaiser-Karl-V-Allee 3, Bad Abbach, 93077, Germany

关键词: Prophylaxis;    Fracture;    Therapy;    Trauma;    Heterotopic ossification;   

Others  :  1232767
DOI  :  10.1186/s12891-015-0764-2

 received in 2015-02-08, accepted in 2015-10-08,  发布年份 2015

【 摘 要 】

Background

Heterotopic ossification (HO) is a complication after tissue trauma, fracture and surgery (i.e. total hip arthroplasty). Prophylaxis is the most effective therapy. If HO formations become symptomatic and limit patients’ quality of life, revision surgery is indicated and is usually combined with a perioperative oral prophylaxis (NSAIDs) and/or irradiation. However, a long-term use of NSAIDs can induce gastro-intestinal or cardiac side-effects and possible bony non-unions during fracture healing. Subject of this study was to assess the current status of HO prophylaxis after injuries or fractures and to evaluate current indications and strategies for excision of symptomatic HO.

Methods

Between 2013 and 2014, a questionnaire was sent to 119 orthopaedic and trauma surgery departments in Germany. Participation was voluntary and all acquired data was given anonymously.

Results

The cumulative feedback rate was 71 %. Trauma and orthopaedic surgery departments in Germany recommend oral HO prophylaxis after acetabulum and femoral neck fractures, elbow dislocation, and fracture or dislocation of the radial head. Pain upon movement and an increasing loss of range of motion in the affected joint are considered to be clear indications for HO surgery. A partial removal of ROM-limiting HO formations was also considered important. The vast majority of all departments include perioperative oral HO prophylaxis and/or irradiation if surgical HO removal is planned. The choice and duration of NSAIDs is highly variable.

Conclusion

HO is of clinical significance in current traumatology and orthopaedics. Certain fractures and injuries are prone to HO, and prophylactic measures should be taken. The respondents in this survey assessed current therapeutic strategies for HO formations similarly. These concepts are in line with the literature. However, the duration of perioperative oral HO prophylaxis varied greatly among the specialist centres. This is significant as a long-term use of NSAIDs fosters a potential risk for the patients’ safety and could influence the clinical outcome. National and international guidelines need to be developed to further reduce HO rates and improve patients’ safety in trauma and orthopaedic surgery.

【 授权许可】

   
2015 Winkler et al.

【 参考文献 】

• [1]Jackson W, Aragon A, Djouad F, Song Y, Koehler S, Nesti L et al.. Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med. 2009; 3:129-38.
• [2]Citak M, Suero EM, Backhaus M, Aach M, Godry H, Meindl R et al.. Risk factors for heterotopic ossification in patients with spinal cord injury: a case–control study of 264 patients. Spine. 2012; 37:1953-7.
• [3]Beck A, Salem K, Krischak G, Kinzl L, Bischoff M, Schmelz A. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the perioperative phase in traumatology and orthopedics effects on bone healing. Oper Orthop Traumatol. 2005; 17:569-78.
• [4]Pountos I, Georgouli T, Calori GM, Giannoudis PV. Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis. ScientificWorldJournal. 2012;2012.
• [5]Ippolito E, Formisano R, Farsetti P, Caterini R, Penta F. Excision for the treatment of periarticular ossification of the knee in patients who have a traumatic brain injury. J Bone Joint Surg Am. 1999; 81:783-9.
• [6]Ashton LA, Bruce W, Goldberg J, Walsh W. Prevention of heterotopic bone formation in high risk patients post-total hip arthroplasty. J Orthop Surg (Hong Kong). 2000; 8:53-7.
• [7]AWMF-German Study Group for the Council for International Organizations of Medical Sciences CIOMS [http://www.awmf.org/]. Accessed August 2015.
• [8]Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys. 2006; 65:1289-99.
• [9]Brighton CT, Schaffer JL, Shapiro DB, Tang JJ, Clark CC. Proliferation and macromolecular synthesis by rat calvarial bone cells grown in various oxygen tensions. J Orthop Res. 1991; 9:847-54.
• [10]Alfieri KA, Forsberg JA, Potter BK. Blast injuries and heterotopic ossification. Bone Joint Res. 2012; 1:192-7.
• [11]Visser PS, Krosnick JA, Marquette J, Curtin M. “Mail surveys for election forecasting? An evaluation of the Colombia Dispatch Poll.”. Public Opinion Quarterly. 1996; 60:181-227.
• [12]Keeter S, Kennedy C, Dimock M, Best J, Craighill P. Gauging the impact of growing nonresponse on estimates from a national RDD telephone survey. Public Opinion Quarterly. 2006; 70:759-79.
• [13]Moed BR, Maxey JW. The effect of indomethacin on heterotopic ossification following acetabular fracture surgery. J Orthop Trauma. 1993; 7:33-8.
• [14]Griffin SM, Sims SH, Karunakar MA, Seymour R, Haines N. Heterotopic ossification rates after acetabular fracture surgery are unchanged without indomethacin prophylaxis. Clin Orthop Relat Res. 2013.
• [15]Foruria AM, Augustin S, Morrey BF, Sánchez-Sotelo J. Heterotopic ossification after surgery for fractures and fracture-dislocations involving the proximal aspect of the radius or ulna. J Bone Joint Surg Am. 2013; 95:e66.
• [16]Johansson T, Risto O, Knutsson A, Wahlström O. Heterotopic ossification following internal fixation or arthroplasty for displaced femoral neck fractures: a prospective randomized study. Int Orthop. 2001; 25:223-5.
• [17]Zeckey C, Hildebrand F, Mommsen P, Schumann J, Frink M, Pape H-C et al.. Risk of symptomatic heterotopic ossification following plate osteosynthesis in multiple trauma patients: an analysis in a level-1 trauma centre. Scand J Trauma Resusc Emerg Med. 2009; 17:55. BioMed Central Full Text
• [18]Simonsen LL, Sonne-Holm S, Krasheninnikoff M, Engberg AW. Symptomatic heterotopic ossification after very severe traumatic brain injury in 114 patients: incidence and risk factors. Injury. 2007; 38:1146-50.
• [19]Cobb TK, Berry DJ, Wallrichs SL, Ilstrup DM, Morrey BF. Functional outcome of excision of heterotopic ossification after total hip arthroplasty. Clin Orthop Relat Res. 1999; 361:131-9.
• [20]Salazar D, Golz A, Israel H, Marra G. Heterotopic ossification of the elbow treated with surgical resection: risk factors, bony ankylosis, and complications. Clin Orthop Relat Res. 2014.
• [21]McAuliffe JA, Wolfson AH. Early excision of heterotopic ossification about the elbow followed by radiation therapy. J Bone Joint Surg Am. 1997; 79:749-55.
• [22]Sheybani A, Tennapel MJ, Lack WD, Clerkin P, Hyer DE, Sun W, et al. Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: a case–control analysis. Int J Radiat Oncol Biol Phys. 2014.
• [23]Vasileiadis GI, Sakellariou VI, Kelekis A, Galanos A, Soucacos PN, Papagelopoulos PJ et al.. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin? J Musculoskelet Neuronal Interact. 2010; 10:159-65.
• [24]Shimono K, Tung W-E, Macolino C, Chi AH-T, Didizian JH, Mundy C et al.. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists. Nat Med. 2011; 17:454-60.
• [25]Salisbury E, Rodenberg E, Sonnet C, Hipp J, Gannon FH, Vadakkan TJ et al.. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem. 2011; 112:2748-58.
• [26]Shrivats AR, Hollinger JO. The Delivery and Evaluation of RNAi Therapeutics for Heterotopic Ossification Pathologies. Methods Mol Biol. 2014;1202:149–60. doi:. 10. 1007/7651_2013_34 webcite